Outcome of hepatitis C infection: Bleak or benign?

Journal of Hepatology

Volumn 47, Issue 1, 2007, Pages 4-6

  Ryder, Stephen D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALCOHOL ABUSE; AUSTRIA; DIABETES MELLITUS; DISEASE COURSE; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIFESTYLE; LIVER CANCER; LIVER FIBROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR;

DISEASE PROGRESSION; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; PROGNOSIS; RISK;

EID: 34249313696     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.04.006     Document Type: Editorial

References (16)

1. El-Serag H.B., Davila J.A., Petersen N.J., and McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817-823
2. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
3. Freeman A.J., Dore G.J., Law M.G., Thorpe M., Von Overbeck J., Lloyd A.R., et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34 (2001) 809-816
4. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340 (1999) 1228-1233
5. Wiese M., Grüngreiff K., Güthoff W., Lafrenz M., Oesen U., Porst H., et al. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25 year multicentre study. J Hepatol 43 (2005) 590-598
6. Ferenci P., Ferenci S., Datz C., Rezman I., Oberaigner W., and Strauss R. Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s. J Hepatol 47 (2007) 31-36
7. Poynard T., Ratziu V., Charlotte F., Goodman Z., McHutchison J., and Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol 34 (2001) 730-739
8. Ryder S.D. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 53 (2004) 451-455
9. Wali M., Harrison R.F., Gow P.J., and Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 51 (2002) 248-252
10. Mohsen A.H. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 48 (2001) 707-713
11. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78 (1997) 1527-1531
12. Hourigan L.F., Macdonald G.A., Purdie D., Whitehall V.H., Shorthouse C., Clouston A., et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29 (1999) 1215-1219
13. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.-F., Utili R., Ruggiero G., et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33 (2001) 1358-1364
14. Westin J., Nordlinder H., Lagging M., Norkrans G., and Wejstål R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 37 (2002) 837-842
15. Amin J., Law M.G., Bartlett M., Kaldor J.M., and Dore G.J. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 368 (2006) 938-945
16. Neal K., and Irving W.L. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: A prospective study. Gut (2007) 10.1136/gut.2006.113217